Manufacturing Bacteriophages (Part 1 of 2): Cell Line Development, Upstream, and Downstream Considerations

• Váldodahkkit: Tayfun Tanir (Dahkki), Marvin Orellana (Dahkki), Aster Escalante (Dahkki), Carolina Moraes de Souza (Dahkki), Michael S. Koeris (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2021-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Within this first part of the two-part series on phage manufacturing, we will give an overview of the process leading to bacteriophages as a drug substance, before covering the formulation into a drug product in the second part. The principal goal is to provide the reader with a comprehensive framew...